Iovance Biotherapeutics Inc
SWB:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
B
|
Biogen Inc
XHAM:IDP
|
US |
|
B
|
Bunge Ltd
F:BU3
|
US |
|
K
|
Kadant Inc
F:KDA
|
US |
|
MaxCyte Inc
F:MYE0
|
US |
|
C
|
Century Casinos Inc
F:CNT
|
US |
|
N
|
Nov Inc
BMV:NOV
|
US |
|
Fonix Mobile PLC
LSE:FNX
|
UK |
|
A
|
Atlanta Braves Holdings Inc
NASDAQ:BATRA
|
US |
|
H
|
Hapag Lloyd AG
F:HLAG
|
DE |
|
E
|
Electronic Arts Inc
DUS:ERT
|
US |
|
M
|
Mitsui Chemicals Inc
SWB:MSI
|
JP |
|
K
|
Kforce Inc
XMUN:ROF
|
US |
|
C
|
CenterPoint Energy Inc
DUS:HOU
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
H
|
H & R Block Inc
SWB:HRB
|
US |
|
L
|
Legence Corp
NASDAQ:LGN
|
US |
|
N
|
Nike Inc
XHAM:NKE
|
US |
|
M
|
MGP Ingredients Inc
F:M1I
|
US |
|
H
|
Hapag Lloyd AG
SWB:HLAG
|
DE |
Multiples-Based Value
The Multiples-Based Value for
Iovance Biotherapeutics Inc (2LB) under the Base Case is hidden
EUR.
Compared with the current market price of 3.445 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.